OKYO Pharma Ltd ADR (OKYO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.72
• Market Cap: $89.89M
• EPS: $-0.12
• 52-Week High: $3.35
• 52-Week Low: $1.03

Market Sentiment

OKYO Pharma Ltd ADR currently has a Bullish sentiment score of 0.41.

About OKYO Pharma Ltd ADR

OKYO Pharma Ltd ADR is a preclinical biopharmaceutical company based in London, UK, specializing in the development of innovative therapies for inflammatory eye diseases and ocular pain. The company is leveraging advanced research to address significant unmet medical needs in the ophthalmology sector. With a focused pipeline and a commitment to innovation, OKYO is positioned to potentially transform the landscape of ocular therapeutics, offering promising solutions for patients suffering from...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for OKYO Pharma Ltd ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OKYO pay dividends?

OKYO Pharma Ltd ADR (OKYO) does not currently pay a regular dividend.

What is OKYO's market cap?

OKYO Pharma Ltd ADR (OKYO) has a market capitalization of $89.89M with a current stock price of $1.72.